Industries
Nanomedicine
Nanomedicine applies nanoscale drug carriers such as LNPs, polymeric micelles, and dendrimers to improve the delivery, pharmacokinetics, and tumor accumulation of small molecules, nucleic acids, and biologics. The siRNA delivery revolution drew heavily from university polymer chemistry and biophysics labs whose LNP and conjugate chemistry innovations are now licensed worldwide.
Details
- Companies
- Silence TherapeuticsArrowhead PharmaceuticalsAlnylam PharmaceuticalsSerina TherapeuticsPolymun ScientificTarveda TherapeuticsNanoCarrierPrecision BioSciencesCerephex NovenNuvation Bio
- Market Size
- $9.2B
- Target Researchers
- Pharmaceutical scientists, biophysicists, and cell biologists specializing in lipid nanoparticle design, polymeric micelles, dendrimers, inorganic nanocarriers, active and passive tumor targeting, and in vivo biodistribution profiling
- Use Cases
- LNP-siRNA delivery IP licensingTumor-targeted nanoparticle co-developmentPEGylation chemistry accessNanoparticle surface functionalization consultingIn vivo imaging probe supplyActive targeting ligand library licensing